Profhilo is an injectable skin treatment made from highly purified hyaluronic acid (HA). Its not a traditional filler that adds volume. Instead its designed to hydrate, stimulate collagen and elastin production, and remodel skin quality from within. HA attracts and holds water which plumps and hydrates tissue while triggering fibroblasts to make new collagen and elastin. This gives a gradual improvement in skin firmness, elasticity, and texture.
Our dataset currently has 20 clinic(s), with approximately 1341 reviews and an average rating of 4.93.
Medical Infrastructure:
- Countess of Chester Hospital (NHS Foundation Trust)
- Multiple private hospitals and CQC-registered independent clinics
- Strong GP network
- Cross-border patient flow from North Wales.
Local Aethetics Market:
Highly mature and competitive across injectables, dermatology and surgical aesthetics.
Profhilo itself has regulatory approvals (MHRA and FDA reported in some sources) confirming it's safety profile as an injectable HA treatment. However specific NICE procedural guidance may be limited, and UK practice of cosmetic injectables lacks strict regulation on who can provide treatments, so clinician judgement and adherence to best practices matter.
Local regulatory authority:
- Care Quality Commission (CQC) for regulated medical services in England
- Practitioner regulation via General Medical Council (GMC) and Nursing and Midwifery Council (NMC).
Private insurance usage locally:
- High for medically indicated dermatology and reconstructive surgery
- Elective cosmetic procedures predominantly self-funded.
Cosmetic finance availability:
- Widely available for surgical procedures (e.g., rhinoplasty, breast augmentation, liposuction)
- Finance partnerships common among surgical clinics.
Current average rating citywide: 4.93